@article{bc7134bf3b5c4b1aa487c51081ebfbe0,
title = "Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing",
abstract = "Altering the human epigenome with gene-editing technology in attempt to treat a variety of diseases and conditions seems scientifically feasible. We explore some of the ethical and regulatory issues related to the clinical translation of human epigenetic editing arguing that such approaches should be considered akin to somatic therapies.",
author = "Nikolajs Zeps and Tamra Lysaght and Ruth Chadwick and Alexandre Erler and Roger Foo and Simona Giordano and {San Lai}, Poh and Schaefer, {G. Owen} and Vicki Xafis and Chew, {Wei Leong} and Jeremy Sugarman",
note = "Funding Information: This work is part of the SHAPES Gene Modifying Technologies (GMT) Project. The GMT Working Group was chaired by R.C. and P.S.L.. All papers produced by SHAPES GMT Working Group members were funded and supported by the Singapore National Medical Research Council Research, Innovation and Enterprise 2020 Grant. Publisher Copyright: {\textcopyright} 2021 The Authors",
year = "2021",
month = jul,
day = "13",
doi = "10.1016/j.stemcr.2021.06.004",
language = "English",
volume = "16",
pages = "1652--1655",
journal = "Stem Cell Reports",
issn = "2213-6711",
publisher = "Cell Press",
number = "7",
}
